Reimbursement changes drive greater interest in CCTA

Liz Carey Feature Writer Smg 2023 Headshot

When the U.S. Centers for Medicare and Medicaid Services (CMS) doubled the reimbursement for coronary CT angiography (CCTA) beginning in 2025, the higher payment incentive opened the door for wider acceptance and adoption of 3D imaging in cardiac and diagnostic programs.

The CMS had long said evidence demonstrated that CCTA could reliably rule out the presence of significant coronary artery disease (CAD) in certain patients and could reliably achieve a high degree of diagnostic accuracy and technical performance necessary to replace conventional angiography.

With radiologists, cardiologists, CT and 3D technologists, and nurses essential to a cardiac CCTA imaging program, hospital and practice administrators are learning what the CMS's 2025 payment position means for their operations.